Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target ...

Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that develops, manufactures, and markets a broad range of innovative products.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

NASA is fueling an exciting future for citizen science by funding 25 new projects across diverse fields, from astrophysics to ...

Bringing Pittcon to Boston represents a perfect alignment of mission and location,” said Heather Juzwa, President of Pittcon 2025. “The city’s concentration of scientific talent, from ...

The Gastro+™ is easy-to-use and a non-invasive breath hydrogen monitor, with two sampling modes and a colour touch screen. The monitor is quick and easy use, with visual prompts for patients ...